| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/21/2006 | WO2006099537A2 The use of antibody-surrogate antigen systems for detection of analytes |
| 09/21/2006 | WO2006099514A2 Drug delivery compositions and related methods |
| 09/21/2006 | WO2006099313A2 Phosphate conjugates of prenylation inhibitors |
| 09/21/2006 | WO2006099279A2 Elastomeric fising lure body |
| 09/21/2006 | WO2006099258A1 Tigecycline compositions and methods of preparation |
| 09/21/2006 | WO2006098754A2 A suspension comprising an active principle, a suspending vehicle, a density-modifying solid with an increased physical stability |
| 09/21/2006 | WO2006098680A1 The use of a hydrophobic zeolite, that contains and gives a slow release of an active element, for treatment of skin |
| 09/21/2006 | WO2006098650A1 Light pharmaceutical water and therapeutic compositions and methods thereof |
| 09/21/2006 | WO2006098496A1 Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same |
| 09/21/2006 | WO2006098463A1 Polynucleic acid-binding substance |
| 09/21/2006 | WO2006098415A1 Drug carrier |
| 09/21/2006 | WO2006098353A1 External preparation |
| 09/21/2006 | WO2006098241A1 Pharmaceutical composition containing hardly water soluble medicament |
| 09/21/2006 | WO2006097793A2 Compositions capable of facilitating penetration across a biological barrier |
| 09/21/2006 | WO2006097537A2 Acylated glp-1 compounds |
| 09/21/2006 | WO2006097536A2 Dimeric peptide agonists of the glp-1 receptor |
| 09/21/2006 | WO2006097521A1 Pegylated single-chain insulin |
| 09/21/2006 | WO2006097458A1 Novel combination |
| 09/21/2006 | WO2006096970A1 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 09/21/2006 | WO2006096955A1 Vehicle for topical delivery of anti-inflammatory compounds |
| 09/21/2006 | WO2006096953A1 Use of crotamine, kit and composition |
| 09/21/2006 | WO2006096914A1 A topical analgesic composition |
| 09/21/2006 | WO2006096913A1 A topical anaesthetic composition |
| 09/21/2006 | WO2006084141A3 Suspension formulation of interferon |
| 09/21/2006 | WO2006080412A3 Cyanopyrrolidine derivative-containing composition for solid pharmaceutical preparations, solid pharmaceutical preparation containing the composition, and process for producing the solid pharmaceutical preparation |
| 09/21/2006 | WO2006076124A3 Stable, non-crystalline formulation comprising olanzapine |
| 09/21/2006 | WO2006067138A3 Injectable veterinary composition |
| 09/21/2006 | WO2006046951A3 Cell cycle arrest and apoptosis |
| 09/21/2006 | WO2006044101A3 Method and composition for supplementation of nutritional deficiencies in renal patients |
| 09/21/2006 | WO2006042848A3 Growth hormone conjugates |
| 09/21/2006 | WO2006038110A8 Amphiphilic star block copolymers |
| 09/21/2006 | WO2006007412A9 Peptide yy formulations having increased stability and resistance to microbial agents |
| 09/21/2006 | WO2006004390A3 Preparation and use of a bivalent vaccine against morphine-heroin addiction |
| 09/21/2006 | WO2005090395A3 Methods for increasing protein polyethylene glycol (peg) conjugation |
| 09/21/2006 | WO2005046730A3 Biotin-facilitated transport into gram negative bacteria |
| 09/21/2006 | US20060212025 Method and apparatus for acne treatment |
| 09/21/2006 | US20060211982 Intracutaneous injection |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211805 Redispersible powder and its aqueous dispersion, preparation process and use |
| 09/21/2006 | US20060211773 1-(12-Amino-4,9-diazadodecyl)-2-methyl-3-hydroxy-4(1H)-pyridinone; increase transport across a cell membrane in order to increase the effectiveness of chelation therapy; metal (iron) overload condition, anticarcinogenic, antitumor agent; positively charged at physiological pH; reducing oxidative stress |
| 09/21/2006 | US20060211688 Vehicle for topical delivery of anti-inflammatory compounds |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211654 Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor |
| 09/21/2006 | US20060211637 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 09/21/2006 | US20060211599 Reversibly heat-gelable aqueous composition |
| 09/21/2006 | US20060211113 Method and system for introducing a gene into a human stem cell |
| 09/21/2006 | US20060210641 Absorbable microparticles |
| 09/21/2006 | US20060210635 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 09/21/2006 | US20060210629 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 09/21/2006 | US20060210622 Surface modified particulate compositions of biologically active substances |
| 09/21/2006 | US20060210618 Polyglycrine based phospholipid containing amide groups; surfactant, solubilizer, dispersant for cosmetics, lipid membrane for drug delivery systems |
| 09/21/2006 | US20060210615 Dermal or transdermal therapeutic system comprising an ormocer with barrier effect on a cover foil |
| 09/21/2006 | US20060210614 Method of treatment of a metabolic disease using intranasal administration of exendin peptide |
| 09/21/2006 | US20060210610 Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
| 09/21/2006 | US20060210609 Fucoidan compositions and methods for dietary and nutritional supplements |
| 09/21/2006 | US20060210608 Mineral composition |
| 09/21/2006 | US20060210606 Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
| 09/21/2006 | US20060210599 Injectable or sprayable nonpolymeric ester or mixed ester solution easily formulated with therapeutic agents |
| 09/21/2006 | US20060210593 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same |
| 09/21/2006 | US20060210587 Virus-like particles for the induction of autoantibodies |
| 09/21/2006 | US20060210571 Engineering antibodies that bind irreversibly |
| 09/21/2006 | US20060210552 Compositions and methods for systemic inhibition of cartilage degradation |
| 09/21/2006 | US20060210550 Angiogenesis inducer |
| 09/21/2006 | US20060210534 Pegylated interleukin-10 |
| 09/21/2006 | US20060210531 Agent eleveting dendritic cell precursor level in blood |
| 09/21/2006 | US20060210528 Therapy for tropical diseases |
| 09/21/2006 | US20060210526 polyoxyethylene glycol-protein conjugate linked via linking group |
| 09/21/2006 | US20060210477 Therapeutic agent for cancer |
| 09/21/2006 | US20060210473 VEGF-conjugate combined methods for tumor vasculature targeting and tumor treatment |
| 09/21/2006 | DE102005042875A1 Schnell freisetzende Darreichungsformen für Antibiotika Quick-release dosage forms of antibiotics |
| 09/21/2006 | DE102005012300A1 Use of esters of 2-propylheptanols with (di)carbonic acids in cosmetic and/or pharmaceutical composition for cleaning human skin and hair; and for eliminating body odor |
| 09/21/2006 | DE102005011691A1 Cosmetic and/or pharmaceutical composition, useful for cleaning and protecting the human skin and hair, comprises hydrocarbon, which is obtained by kolbe electrolysis of fatty acids |
| 09/21/2006 | DE102005009853A1 Cosmetic and/or pharmaceutical composition, useful for cleaning and protecting the human skin and hair, comprises hydrocarbon, which is obtained by kolbe electrolysis of fatty acids |
| 09/21/2006 | CA2656966A1 A topical analgesic composition |
| 09/21/2006 | CA2656961A1 A topical anaesthetic composition |
| 09/21/2006 | CA2602089A1 Tigecycline compositions and methods of preparation |
| 09/21/2006 | CA2602031A1 Nanoparticles of chitosan and polyethyleneglycol as a system for the administration of biologically-active molecules |
| 09/21/2006 | CA2601784A1 Acylated glp-1 compounds |
| 09/21/2006 | CA2601123A1 External preparation |
| 09/21/2006 | CA2600851A1 The use of antibody-surrogate antigen systems for detection of analytes |
| 09/21/2006 | CA2600696A1 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 09/21/2006 | CA2578524A1 A suspension comprising an active principle, a suspending vehicle, a density-modifying solid with an increased physical stability |
| 09/21/2006 | CA2563533A1 Compositions capable of facilitating penetration across a biological barrier |
| 09/20/2006 | EP1703014A1 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 09/20/2006 | EP1702983A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof |
| 09/20/2006 | EP1702914A1 Radio-opaque polymeric biomaterials |
| 09/20/2006 | EP1702886A1 Porous silica having substance carried thereon |
| 09/20/2006 | EP1702619A2 Disinfecting and solubilizing steroid compositions |
| 09/20/2006 | EP1702597A2 Drug delivery of phase changing formulation |
| 09/20/2006 | EP1702161A2 Oxidative reductive potential water solution, processes for producing same and methods of using the same |
| 09/20/2006 | EP1702069A2 Interleukin-12 targeted to oncofoetal fibronectin |
| 09/20/2006 | EP1701981A1 Cohesive gels from cross-linked hyaluronan and/or hylan,their preparation and use |
| 09/20/2006 | EP1701980A1 A simplified method to retrieve chitosan from acidic solutions thereof |
| 09/20/2006 | EP1701745A1 Gas-filled microvesicle assembly for contrast imaging |
| 09/20/2006 | EP1701744A2 Thiol-cleavable linkage between polymer and ligand |
| 09/20/2006 | EP1701743A2 Potentiation of the activation of high-molecular-mass prodrugs |
| 09/20/2006 | EP1701742A2 Intranasal compositions comprising zolpidem |
| 09/20/2006 | EP1701737A2 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 09/20/2006 | EP1701709A2 Confection product containing urea |
| 09/20/2006 | EP1701701A1 Methods of preparing a foam comprising a sclerosing agent |